A new international guideline has been developed to help physicians diagnosis idiopathic pulmonary fibrosis (IPF), a rare and often fatal lung disease whose cause is unknown. The 2018 clinical practice guideline was developed by experts representing four major respiratory societies.
The respiratory societies are: the American Thoracic Society (ATS), the European Respiratory Society (ERS), Japanese Respiratory Society (JRS) and the Latin American Thoracic Society (ALAT)--and published online
Wilt u meer lezen? Log dan in.